How to check the XIRR of Mirae Asset Healthcare Fund Direct Growth?

You can track the exact XIRR and portfolio overlapping of Mirae Asset Healthcare Fund Direct Growth alongside your PMS and AIF investments using the MutualSaathi Portfolio Analyzer.

How to check portfolio overlap for Mirae Asset Healthcare Fund Direct Growth?

Use the MutualSaathi Portfolio Analyzer to compare Mirae Asset Healthcare Fund Direct Growth with other funds, PMS, and AIFs to detect hidden stock overlaps.

Mirae Asset Healthcare Fund Direct Growth

Mirae Asset Mutual Fund

Expense Ratio: 0.48

Risk: Very High

Equity Scheme - Sectoral/ Thematic

Plan: Direct

Benchmark: BSE Healthcare TRI

Inception: 11-06-2018

Exit Load: Nil

Fund Size:₹2,791.33 Cr

Performance

Fund13.95%

Cat. Avg.N/A

Fund6.86%

Cat. Avg.N/A

Fund21.28%

Cat. Avg.N/A

Fund14.59%

Cat. Avg.N/A

10Y

FundN/A

Cat. Avg.N/A

Fund21.25%

Cat. Avg.N/A

Fund Facts

No available Data

Taxation

Within 1 Year (STCG (Short Term)):20%

After 1 Year (LTCG (Long Term)):12.5%

*Tax rates as per Finance Act 2024. Surcharge & cess may apply.

Allocation

Visualizing Fund's Exposure

Asset Class

Tap to expand

Market Cap

Tap to expand

Top Sectors

Tap to expand

Asset Class

Market Cap

Top Sectors

Portfolio Holdings

Detailed breakdown of instruments.

	Instrument	Type	Sub-Cat	Cap	Sector	Val (Cr)	% Assets
1	Sun Pharmaceutical Industries Ltd.	Equity	Listed	Large Cap	Pharmaceuticals & Biotechnology	356.13	10.95%
2	Divi's Laboratories Ltd.	Equity	Listed	Large Cap	Pharmaceuticals & Biotechnology	244.86	7.53%
3	JB Chemicals & Pharmaceuticals Ltd.	Equity	Listed	Small Cap	Pharmaceuticals & Biotechnology	211.07	6.49%
4	Apollo Hospitals Enterprise Ltd.	Equity	Listed	Large Cap	Healthcare Services	198.21	6.09%
5	Glenmark Pharmaceuticals Ltd.	Equity	Listed	Mid Cap	Pharmaceuticals & Biotechnology	198.03	6.09%
6	Laurus Labs Ltd.	Equity	Listed	Mid Cap	Pharmaceuticals & Biotechnology	149.88	4.61%
7	Dr. Reddy's Laboratories Ltd.	Equity	Listed	Mid Cap	Pharmaceuticals & Biotechnology	140.88	4.33%
8	Aurobindo Pharma Ltd.	Equity	Listed	Mid Cap	Pharmaceuticals & Biotechnology	140.87	4.33%
9	Lupin Ltd.	Equity	Listed	Mid Cap	Pharmaceuticals & Biotechnology	134.30	4.13%
10	Krishna Institute of Medical Sciences Ltd.	Equity	Listed	Small Cap	Healthcare Services	125.18	3.85%

Similar Funds

SIP Returns

Amount (₹)

Date

7th

Period	SIP Date	Inv(₹)	Val(₹)	Abs(%)	XIRR
1Y	07 Nov, 25	60000	64701	+7.8%	+16.7%
2Y	07 Nov, 24	1.20 L.	1.36 L.	+13.7%	+13.6%
3Y	07 Nov, 23	1.80 L.	2.23 L.	+23.6%	+14.8%
5Y	08 Nov, 21	3 L.	4.75 L.	+58.4%	+18.9%
SI	09 Jul, 18	5 L.	12.24 L.	+144.8%	+21.0%

Lumpsum Returns

Amount (₹)

Period	Inv Date	Inv(₹)	Val(₹)	Abs(%)	CAGR
1Y	16 Oct, 25	1 L.	1.14 L.	+13.9%	+14.0%
2Y	16 Oct, 24	1 L.	1.14 L.	+14.2%	+6.9%
3Y	16 Oct, 23	1 L.	1.78 L.	+78.4%	+21.3%
5Y	18 Oct, 21	1 L.	1.99 L.	+99.1%	+14.8%
SI	03 Jul, 18	1 L.	4.94 L.	+394.3%	+21.3%

SIP Calculator

Visualize how small monthly investments grow over time.

Monthly SIP Amount

Max: ₹10 Cr

₹

Investment Tenure

Max: 40 Years

Years

Expected Annual Return (SIP)

Max: 30%

Expected Inflation

Max: 20%

Annual Step-up

Beat inflation and compound wealth faster with an annual step-up.

Max: 500%

Initial Lumpsum

Max: ₹1000 Cr

₹

Expected Return on Lumpsum

Max: 30%

Future Value

₹23.80L

With SIP Amount ₹5,000

Total Invested

₹9.00L

Total Profit

₹14.80L

SIP Invested₹9.00L

SIP Gain₹14.80L

Lumpsum Inv.₹0

Lumpsum Gain₹0

Reality Check: Your future value will be today's ₹8.62L at inflation rate 7%

Tip: You can set a Goal first in the Goal Planner to calculate SIP targets adjusted for inflation.